Insulin and oral agents for managing cystic fibrosis-related diabetes
Author:
Affiliation:
1. Wright State University; Boonshoft School of Medicine; Room 105, Medical Sciences Building 3640 Colonel Glenn Highway Dayton Ohio USA OH 45435
2. Children's Medical Center; Department of Pediatrics; One Children's Plaza Dayton Ohio USA OH 45404
Publisher
Wiley
Subject
Pharmacology (medical)
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD004730.pub4/fullpdf
Reference51 articles.
1. Open randomised prospective comparative multi-centre intervention study of patients with cystic fibrosis and early diagnosed diabetes mellitus;Ballmann;BMC Pediatrics,2014
2. Repaglinide versus insulin in the treatment of CFRD diagnosed by screening: an open prospective randomized study [abstract];Ballmann;Pediatric Pulmonology,2013
3. Treatment of early diagnosed CFRD with oral drugs verus insulin: An open prospective randomized study [abstract];Ballmann;Journal of Cystic Fibrosis,2013
4. Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test;Schmid;Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society,2014
5. Glargine versus NPH insulin in cystic fibrosis related diabetes;Grover;Journal of Cystic Fibrosis,2008
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Current Perspectives and Innovative Approaches in Treating Cystic Fibrosis-Related Diabetes: Unveiling Mechanisms for Precision Medicine;Current Drug Therapy;2024-05-24
2. Canadian Cystic Fibrosis–related Diabetes Clinical Practice Survey: Analysis of Current Practices and Gaps in Clinical Care;Canadian Journal of Diabetes;2023-04
3. Cystic Fibrosis-related Diabetes;Contemporary Endocrinology;2023
4. 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes—2023;Diabetes Care;2022-12-12
5. ISPAD Clinical Practice Consensus Guidelines 2022: Management of cystic fibrosis‐related diabetes in children and adolescents;Pediatric Diabetes;2022-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3